IPAS770
Concessão de registro em designação
RPI 2813
12/03/2024
Back to search
Official data from INPI
ZATESPRI
Did you know this trademark is already registered in Brazil?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Registro de marca em vigor (Madri)Type: WordOffice: Brazil
Progress at the INPI
- Filing05/22/23
- Publication01/23/24
- Examination
- Allowance10/22/24
- Grant12/03/24
- In force05/22/33
The registration was granted on 12/03/2024 and is in force until 05/22/2033, when it must be renewed.
Protection valid until:05/22/2033
Latest action published by the INPI: 12/03/2024. We update with every new RPI gazette, published weekly.
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
INPI status
Registro de marca em vigor (Madri)
Case type
Application and registration
Recorded events
3
Latest update
12/03/2024
Trademark type
Word
Nice classes
5
Filing date
05/22/2023
Registration date
12/03/2024
Expiration date
05/22/2033
Complete case details
Structured fields from the responsible authority and the official record.
Nature
Madri
Produto/Serviço
Responsible office
Brazil
Owner type
NÃO RESIDENTE
Owner location
CH
Holders and representatives
Holders
Novartis AG
Representatives
No representative data.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectivesanti-inflammatoriesantibacterial pharmaceuticalsantibioticsantifungal preparationsantiviralscardiovascular pharmaceuticalsdermatological pharmaceutical preparationsinhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorderspharmaceutical preparations acting on the central nervous systempharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseasespharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary systempharmaceutical preparations for use in hematology and in tissue and organ transplantationpharmaceutical preparations for the prevention and treatment of eye diseases and conditionspharmaceutical preparations for the prevention and treatment of heart rhythm disorderspharmaceutical preparations for the prevention and treatment of immune system related diseases and disorderspharmaceutical preparations for the prevention and treatment of kidney diseasespharmaceutical preparations for the prevention and treatment of diabetespharmaceutical preparations for the prevention and treatment of hypertensionpharmaceutical preparations for the prevention and treatment of skin disorderspharmaceutical preparations for use in dermatologypharmaceutical preparations for use in urologypharmaceutical preparations for use in ophthalmologypharmaceutical preparations for the prevention and treatment of cancer and tumorspharmaceutical preparations for the prevention and treatment of allergiespharmaceutical preparations for the prevention and treatment of bone diseasespharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publications
History of INPI decisions and trademark events.
3 publications found
IPAS768
Deferimento de designação
RPI 2807
10/22/2024
IPAS756
Publicação de pedido de registro para oposição (exame formal de designação concluído)
RPI 2768
01/23/2024
Novartis AG also protects technology and design at the INPI
2,681 patent applications and 35 industrial designs under the same owner.
Related trademarks
Other trademarks by Novartis AG
Continuous trademark protection
Get notified about every new filing that threatens ZATESPRI or your mark.
Professional 24-month watch service: we monitor INPI for you and alert you in time to oppose — before conflicts become losses.